D-1302A

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameD-1302A
Drug Alias Nametype III anti-CD20 maytansinoid conjugate antibody (ImmunoGen)D-1302A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunogen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A